v3.23.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2021 $ 178,783 $ 3 $ 228,532 $ (10) $ (49,742)
Balance (in shares) at Dec. 31, 2021   29,115,421      
Exercise of stock options 31   31    
Exercise of stock options, (in shares)   6,044      
Issuance of restricted stock (in shares)   47,216      
Stock-based compensation expense 2,330   2,330    
Unrealized gain (loss) on investments, net (13)     (13)  
Net loss (16,366)       (16,366)
Balance at Mar. 31, 2022 164,765 $ 3 230,893 (23) (66,108)
Balance (in shares) at Mar. 31, 2022   29,168,681      
Balance at Dec. 31, 2022 108,539 $ 3 240,107 (1) (131,570)
Balance (in shares) at Dec. 31, 2022   29,561,554      
Exercise of stock options $ 407   407    
Exercise of stock options, (in shares) 44,501 44,501      
Issuance of restricted stock (in shares)   45,079      
Stock-based compensation expense $ 3,233   3,233    
Unrealized gain (loss) on investments, net 1     $ 1  
Net loss (29,051)       (29,051)
Balance at Mar. 31, 2023 $ 83,129 $ 3 $ 243,747   $ (160,621)
Balance (in shares) at Mar. 31, 2023   29,651,134